Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide and CHOP in Untreated PTCL
NCT04423926Phase 2Unknown
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Jun 2020
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in peripheral T-cell lymphoma (PTCL), sponsored by Jiangsu Provincial People's Hospital. Status: unknown.
02
Drugs
lenalidomide
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT04423926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04423926.